R
Ronald F van Vollenhoven
Researcher at University of Amsterdam
Publications - 354
Citations - 32567
Ronald F van Vollenhoven is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 72, co-authored 309 publications receiving 26884 citations. Previous affiliations of Ronald F van Vollenhoven include Karolinska Institutet & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study
Isabel Ferreira,Sara Croca,Maria Gabriella Raimondo,Manjit Matharu,S Miller,Ian Giles,David A. Isenberg,Yiannis Ioannou,John G. Hanly,Murray B. Urowitz,Nicole D. Anderson,Cynthia Aranow,Anca Askanase,Sang Cheol Bae,Sasha Bernatsky,Ian N. Bruce,Jill P. Buyon,Ann E. Clarke,Mary Anne Dooley,Paul R. Fortin,Ellen M. Ginzler,Dafna D. Gladman,Caroline Gordon,Murat Inanc,Søren Jacobsen,Kenneth C. Kalunian,Diane L. Kamen,Munther A. Khamashta,S. Sam Lim,Susan Manzi,Joan T. Merrill,Ola Nived,Christine A. Peschken,Michelle Petri,Rosalind Ramsey-Goldman,Guillermo Ruiz-Irastorza,Jorge Sanchez-Guerrero,Kristjan Steinson,Gunnar Sturfelt,Ronald F van Vollenhoven,Daniel J. Wallace,Asad Zoma,Anisur Rahman +42 more
TL;DR: Serum NN levels rise at the time of an NP event in a proportion of patients with SLE, and the value of serum NN as a biomarker for NPSLE is determined.
Journal ArticleDOI
Rheumatoid arthritis: Missed opportunities in the 2015 ACR guideline for RA treatment.
TL;DR: The new ACR guideline for the treatment of rheumatoid arthritis (RA) is technically solid, but the new recommendations miss some of the most topical issues in RA therapeutics.
Journal ArticleDOI
An ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis?
Cleo Rogier,G. Frazzei,Marion C Kortekaas,M. Verstappen,Sarah Ohrndorf,Elise van Mulligen,Ronald F van Vollenhoven,Dirkjan van Schaardenburg,Pascal H P de Jong,Annette H M van der Helm-van Mil +9 more
TL;DR: A negative US result in arthralgia has a high NPV for not developing IA, which is mainly due to the high a-priori risk ofNot developing IA.
Journal ArticleDOI
Does disease activity at the start of biologic therapy influence health care costs in patients with RA
Kari Johansson,Jonas Eriksson,Ronald F van Vollenhoven,Heather Miller,Johan Askling,Martin Neovius +5 more
TL;DR: Over up to 4 years of follow-up, no difference in health care costs was found after adjustment in patients starting their first biologic treatment with high vs moderate baseline disease activity.
Journal ArticleDOI
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial
Kristina Lend,Ronald F van Vollenhoven,Jon Lampa,Merete Lund Hetland,Espen A Haavardsholm,Dan Nordström,Michael T. Nurmohamed,Bjorn Gudbjornsson,Anna Rudin,Mikkel Østergaard,Till Uhlig,Gerdur Grondal,Kim Hørslev-Petersen,Marte Schrumpf Heiberg,T. Sokka-Isler,F. A. Koopman,Jos W. R. Twisk,Irene E. van der Horst-Bruinsma +17 more
TL;DR: The NORD-STAR trial as discussed by the authors examined sex differences in remission rates with three different biological treatments combined with methotrexate versus active conventional treatment over 24 weeks, in patients with early rheumatoid arthritis.